Magnesium Nebulization Utilization in Management of Pediatric Asthma (MAGNUMPA)
Sponsor: Alberta Children's Hospital
Listed as NCT01429415, this PHASE2 trial focuses on Acute Asthma and remains completed. Sponsored by Alberta Children's Hospital, it has been updated 10 times since 2011, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
10 versions recorded-
Jan 2026 — Present [monthly]
Completed PHASE2
-
Sep 2024 — Jan 2026 [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE2
-
May 2020 — Jan 2021 [monthly]
Completed PHASE2
▶ Show 5 earlier versions
-
Apr 2020 — May 2020 [monthly]
Completed PHASE2
Status: Recruiting → Completed
-
Nov 2019 — Apr 2020 [monthly]
Recruiting PHASE2
-
Aug 2019 — Nov 2019 [monthly]
Recruiting PHASE2
-
Jun 2018 — Aug 2019 [monthly]
Recruiting PHASE2
-
Jan 2017 — Jun 2018 [monthly]
Recruiting PHASE2
First recorded
Sep 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Alberta Children's Hospital
- Canadian Institutes of Health Research (CIHR)
- Children's Hospital of Eastern Ontario
- Provincial Health Services Authority British Columbia
- St. Justine's Hospital
- Stollery Children's Hospital
- The Children's Hospital of Winnipeg
- The Hospital for Sick Children
For direct contact, visit the study record on ClinicalTrials.gov .